Manufacturing, vectors, applications & regulatory aspects
The last years were very promising for gene therapeutic approaches. A number of successful treatments of cancer or rare diseases were reported, as well as FDA approval of first gene therapeutic products. Until now, these pioneering treatments have been used primarily when conventional therapies reach their limits. Development, manufacturing, quality control and clinical application of gene therapeutic products are very challenging – and still far from routine.
The conference addresses the major issues on the way to save and successful products: “Gene Therapy – Ready for the Market?”
We are proud to announce renowned international Keynote Speakers.
You are most welcome to contribute to the conference programme and submit your paper until 03 September 2018.
The conference is an initiative of the DECHEMA working groups Cell Culture Technology and Medical Biotechnology.